Strategic business solutions provider PointCross, US, has announced the release of its Study Data Integration and Search (SDIS) technology and associated services to the BioPharma industry for private use with legacy and current studies.
SDIS claims to be the first solution of its kind that seeks to close a major gap in the non-clinical phase of the R&D lifecycle. It creates an instantly searchable resource of all non-clinical study and evaluates data for BioPharma companies and collaborative consortia like the C-PATH Predictive Safety Testing Consortium and the Innovative Medicines Initiative (IMI) in Europe.
BioPharma companies and regulatory agencies have growing concerns regarding biomarkers and trends that point to safety and efficacy indications which are hidden in the massive amounts of disparate study data they possess. SDIS can be used for contributing study data in standardised formats to alliance partners and collaborative safety data sharing consortia such as IMI. In-house processes are provided for the selection of study data to be shared from the internal inventory using simple search and redaction facilities to preserve confidentiality.
SDIS is immediately available and can be deployed behind the company firewall, or accessed from a secure PointCross hosted environment.
Search for more Search tools
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
